Dr. Kim Ekroos is one of the pioneers in the field of lipidomics. He obtained his PhD in biology from the Technical University in Dresden, Germany, in 2003. In 2004, he started his postdoctoral work at the department of DMPK & bioanalytical chemistry at AstraZeneca in Mölndal, Sweden. In 2008, he joined Zora Biosciences Oy and became chief technology officer in 2013. In 2016, he founded Lipidomics Consulting Ltd., a consulting business providing unique services for customers globally by designing conclusive mass spectrometry (MS) and experimental approaches to make inroads into cell, disease, biomarker and drug research and development. Today, he is the president of the International Lipidomics Society (ILS; www.lipidomicssociety.org) and spearheading the Lipidomics Standardization Initiative.